⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of MoonLake Immunotherapeutics to Contact the Firm Today!
accessnewswire.com
MLTX
Join Class Action to Recover Losses From MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Informs Shareholders of Securities Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Invites Investors to SueWallSt After MoonLake Immunotherapeutics Stock Collapse
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of December 15, 2025 Deadline
accessnewswire.com
MLTX
MLTX LAWSUIT ALERT: Levi & Korsinsky Notifies MoonLake Immunotherapeutics Investors - Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights - MLTX
prnewswire.com
MLTX
Levi & Korsinsky Releases SueWallSt Podcast on MoonLake Immunotherapeutics (MLTX) Lawsuit
accessnewswire.com
MLTX